Drug intelligence / Profile preview

cephalosporium roseum

Development stage
Unknown
Lead developer
Allermed Laboratories
Administration
Intradermal, Percutaneous, Subcutaneous
01

Overview

Cephalosporium roseum (now taxonomically classified as Trichothecium roseum) is a filamentous fungus primarily recognized in pharmacology as the biological source of the antifungal and antibiotic compound trichothecin. While often confused with Acremonium chrysogenum (formerly Cephalosporium acremonium), which is the source of cephalosporin antibiotics, C. roseum produces distinct metabolites, including rosonolactone and various trichothecenes. In certain traditional and homeopathic practices, preparations derived from the fungus are used to treat various infections and inflammatory conditions, although it is not a standard pharmaceutical agent in modern allopathic medicine. Its primary bioactive constituent, trichothecin, acts by inhibiting eukaryotic protein synthesis through interference with the peptidyl transferase activity on the 60S ribosomal subunit.

Other names
Trichothecium roseum
02

Targets

60S (Eukaryotic 60S ribosomal subunit)PTC (50S ribosomal peptidyl transferase center)

Beyond the preview

Go deeper on cephalosporium roseum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cephalosporium roseum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call